|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
multiple interactions increases expression |
ISO |
[Bezafibrate binds to and results in increased activity of PPARA protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased expression of ABCA1 mRNA]; [Bezafibrate binds to and results in increased activity of PPARA protein] which results in increased expression of ABCA1 mRNA Bezafibrate results in increased expression of ABCA1 mRNA; Bezafibrate results in increased expression of ABCA1 protein |
CTD |
PMID:12595494 PMID:19201410 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases expression affects localization increases expression |
ISO |
Bezafibrate results in decreased expression of ABCB11 mRNA Bezafibrate affects the localization of ABCB11 protein Bezafibrate results in increased expression of ABCB11 mRNA |
CTD |
PMID:15258199 PMID:15447978 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
affects localization multiple interactions increases expression |
ISO EXP |
Bezafibrate affects the localization of ABCB4 protein [Bezafibrate co-treated with Chenodeoxycholic Acid] results in increased expression of ABCB4 mRNA; PPARA protein affects the reaction [Bezafibrate affects the localization of ABCB4 protein] Bezafibrate results in increased expression of ABCB4 mRNA Bezafibrate results in increased expression of ABCB4 mRNA; Bezafibrate results in increased expression of ABCB4 protein |
CTD |
PMID:15242490 PMID:15258199 PMID:15588777 PMID:17118139 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
affects localization increases expression multiple interactions |
ISO |
Bezafibrate affects the localization of ABCC2 protein Bezafibrate results in increased expression of ABCC2 mRNA [Sodium Glutamate co-treated with Bezafibrate] results in increased expression of ABCC2 mRNA |
CTD |
PMID:15258199 PMID:21549692 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
increases transport |
ISO |
ABCC4 protein results in increased transport of Bezafibrate |
CTD |
PMID:17939016 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Abcd3 |
ATP binding cassette subfamily D member 3 |
increases expression |
ISO |
Bezafibrate results in increased expression of ABCD3 protein |
CTD |
PMID:19124612 PMID:20594415 |
|
NCBI chr 2:209,852,087...209,905,763
Ensembl chr 2:209,852,087...209,906,020
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
increases expression |
ISO |
Bezafibrate results in increased expression of ABCG5 mRNA |
CTD |
PMID:14685799 |
|
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
|
|
G |
Acaa1a |
acetyl-CoA acyltransferase 1A |
multiple interactions increases expression |
ISO |
PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of ACAA1A mRNA] |
CTD |
PMID:19124612 |
|
NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
decreases expression increases expression multiple interactions |
ISO |
Bezafibrate results in decreased expression of ACACA mRNA; Bezafibrate results in decreased expression of ACACA protein Bezafibrate results in increased expression of ACACA mRNA; Bezafibrate results in increased expression of ACACA protein PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of ACACA mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of ACACA protein] |
CTD |
PMID:19124612 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acacb |
acetyl-CoA carboxylase beta |
decreases expression multiple interactions increases expression |
ISO |
Bezafibrate results in decreased expression of ACACB mRNA PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of ACACB mRNA] |
CTD |
PMID:17118139 PMID:19124612 |
|
NCBI chr12:42,365,800...42,477,651
Ensembl chr12:42,366,548...42,457,655
|
|
G |
Acadl |
acyl-CoA dehydrogenase, long chain |
multiple interactions increases expression |
ISO |
PPARA protein affects the reaction [Bezafibrate results in increased expression of ACADL mRNA]; PPARA protein affects the reaction [Bezafibrate results in increased expression of ACADL protein] Bezafibrate results in increased expression of ACADL mRNA; Bezafibrate results in increased expression of ACADL protein |
CTD |
PMID:12782154 |
|
NCBI chr 9:68,333,981...68,372,149
Ensembl chr 9:68,333,980...68,372,220
|
|
G |
Acadm |
acyl-CoA dehydrogenase medium chain |
multiple interactions increases expression |
ISO EXP |
Bezafibrate inhibits the reaction [CYP19A1 gene mutant form results in decreased expression of ACADM mRNA]; Bezafibrate inhibits the reaction [SLC27A2 gene mutant form results in decreased expression of ACADM mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of ACADM mRNA] Bezafibrate inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of ACADM mRNA] |
CTD |
PMID:11929713 PMID:19124612 PMID:26190035 |
|
NCBI chr 2:242,858,865...242,883,036
Ensembl chr 2:242,858,865...242,883,147
|
|
G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
affects response to substance increases activity increases expression multiple interactions |
ISO |
ACADVL protein affects the susceptibility to Bezafibrate; ACADVL protein mutant form affects the susceptibility to Bezafibrate Bezafibrate results in increased activity of ACADVL protein Bezafibrate results in increased expression of ACADVL mRNA Butyrates promotes the reaction [Bezafibrate results in increased expression of ACADVL mRNA]; PPARA protein affects the reaction [Bezafibrate results in increased expression of ACADVL mRNA]; PPARA protein affects the reaction [Bezafibrate results in increased expression of ACADVL protein] Bezafibrate inhibits the reaction [ACADVL protein mutant form results in decreased oxidation of Fatty Acids] Bezafibrate results in increased expression of ACADVL mRNA; Bezafibrate results in increased expression of ACADVL protein |
CTD |
PMID:12782154 PMID:17118139 PMID:17999356 PMID:20060901 PMID:22338096 |
|
NCBI chr10:54,732,875...54,738,102
Ensembl chr10:54,732,469...54,738,075
|
|
G |
Ace |
angiotensin I converting enzyme |
multiple interactions |
EXP |
Bezafibrate inhibits the reaction [Streptozocin results in increased expression of ACE mRNA]; Bezafibrate inhibits the reaction [Streptozocin results in increased expression of ACE protein] |
CTD |
PMID:16979161 |
|
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
increases expression multiple interactions increases activity |
ISO EXP |
Bezafibrate results in increased expression of ACOX1 mRNA Bezafibrate results in increased expression of ACOX1 mRNA; Bezafibrate results in increased expression of ACOX1 protein [Sodium Glutamate co-treated with Bezafibrate] results in increased expression of ACOX1 mRNA; Bezafibrate inhibits the reaction [CYP19A1 gene mutant form results in decreased expression of ACOX1 mRNA]; PPARA protein affects the reaction [Bezafibrate results in increased expression of ACOX1 mRNA] Bezafibrate results in increased activity of ACOX1 protein |
CTD |
PMID:2399535 PMID:11172741 PMID:11216866 PMID:11473052 PMID:11519881 PMID:11527545 PMID:11579993 PMID:11929713 PMID:12782154 PMID:15447978 PMID:16574099 PMID:16707586 PMID:17118139 PMID:21324916 PMID:21549692 PMID:21640707 More...
|
|
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
multiple interactions increases expression |
ISO |
Butyrates promotes the reaction [Bezafibrate results in increased expression of ACSL1 mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of ACSL1 mRNA] |
CTD |
PMID:17118139 PMID:19124612 PMID:19682441 PMID:21640707 PMID:22338096 |
|
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
increases expression |
ISO |
Bezafibrate results in increased expression of ACSL4 mRNA |
CTD |
PMID:17118139 |
|
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
|
|
G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
increases expression |
ISO |
Bezafibrate results in increased expression of ACSL5 mRNA |
CTD |
PMID:17118139 |
|
NCBI chr 1:254,289,513...254,336,608
Ensembl chr 1:254,292,521...254,336,607
|
|
G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
affects expression |
EXP |
Bezafibrate affects the expression of ACSS2 mRNA |
CTD |
PMID:17719200 |
|
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions decreases expression |
EXP ISO |
Bezafibrate inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA] Bezafibrate inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of ACTA2 mRNA] Bezafibrate results in decreased expression of ACTA2 protein |
CTD |
PMID:12657956 PMID:18513333 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
increases expression increases secretion multiple interactions |
ISO |
Bezafibrate results in increased expression of ADIPOQ protein Bezafibrate results in increased expression of ADIPOQ mRNA; Bezafibrate results in increased expression of ADIPOQ protein Bezafibrate results in increased secretion of ADIPOQ protein Bezafibrate inhibits the reaction [Sodium Glutamate results in decreased expression of ADIPOQ protein] |
CTD |
PMID:16574099 PMID:17190905 PMID:18513333 PMID:21324916 PMID:21411093 PMID:21549692 More...
|
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adipor1 |
adiponectin receptor 1 |
increases expression |
ISO |
Bezafibrate results in increased expression of ADIPOR1 mRNA |
CTD |
PMID:16574099 |
|
NCBI chr13:45,859,461...45,879,248
Ensembl chr13:45,859,533...45,879,241
|
|
G |
Adipor2 |
adiponectin receptor 2 |
increases expression |
ISO |
Bezafibrate results in increased expression of ADIPOR2 mRNA |
CTD |
PMID:16574099 |
|
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
|
|
G |
Adora2a |
adenosine A2a receptor |
increases expression |
ISO |
Bezafibrate results in increased expression of ADORA2A mRNA |
CTD |
PMID:18787029 |
|
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO EXP |
Bezafibrate inhibits the reaction [AKT1 protein mutant form results in increased susceptibility to Glucose deficiency] [Bezafibrate co-treated with 3-methylglutaric acid] results in decreased expression of AKT1 protein |
CTD |
PMID:15806154 PMID:32169667 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
increases expression |
ISO |
Bezafibrate results in increased expression of ALDH1A2 mRNA |
CTD |
PMID:17118139 |
|
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
|
|
G |
Aldh3a2 |
aldehyde dehydrogenase 3 family, member A2 |
increases activity increases expression affects response to substance |
ISO |
Bezafibrate results in increased activity of ALDH3A2 protein Bezafibrate results in increased expression of ALDH3A2 mRNA ALDH3A2 protein affects the susceptibility to Bezafibrate |
CTD |
PMID:16837225 |
|
NCBI chr10:45,928,313...45,949,366
Ensembl chr10:45,908,524...45,949,281
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
decreases activity multiple interactions increases expression |
ISO |
Bezafibrate results in decreased activity of ALPL protein dorsomorphin inhibits the reaction [Bezafibrate results in increased expression of ALPL mRNA]; GSK0660 inhibits the reaction [Bezafibrate results in increased expression of ALPL mRNA] |
CTD |
PMID:8102192 PMID:21499286 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Angptl4 |
angiopoietin-like 4 |
increases expression |
ISO |
Bezafibrate results in increased expression of ANGPTL4 mRNA |
CTD |
PMID:17118139 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
increases expression |
ISO |
Bezafibrate results in increased expression of APEX1 mRNA |
CTD |
PMID:15447978 |
|
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
Apoa1 |
apolipoprotein A1 |
multiple interactions decreases expression increases expression |
ISO |
[Bezafibrate binds to and results in increased activity of PPARA protein] promotes the reaction [APOA1 protein results in increased transport of Cholesterol]; Bezafibrate promotes the reaction [APOA1 protein results in increased secretion of Lipids] Bezafibrate results in decreased expression of APOA1 mRNA; Bezafibrate results in decreased expression of APOA1 protein Bezafibrate results in increased expression of APOA1 protein |
CTD |
PMID:1323073 PMID:7893284 PMID:7983038 PMID:8017468 PMID:9678787 PMID:10751747 PMID:12595494 PMID:19201410 More...
|
|
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Apoa2 |
apolipoprotein A2 |
increases expression |
ISO |
Bezafibrate results in increased expression of APOA2 protein |
CTD |
PMID:7893284 PMID:8017468 |
|
NCBI chr13:83,644,460...83,646,358
Ensembl chr13:83,644,470...83,646,355
|
|
G |
Apob |
apolipoprotein B |
multiple interactions decreases secretion decreases expression increases expression |
ISO EXP |
Bezafibrate inhibits the reaction [Oleic Acid results in increased expression of APOB protein] PPARA protein affects the reaction [Bezafibrate results in decreased expression of APOB mRNA alternative form]; PPARD protein affects the reaction [Bezafibrate results in decreased expression of APOB mRNA alternative form] Bezafibrate results in decreased secretion of APOB protein [Bezafibrate co-treated with Ethanolamine] results in decreased secretion of APOB protein alternative form Bezafibrate results in increased expression of APOB protein Bezafibrate results in decreased expression of APOB protein |
CTD |
PMID:1323073 PMID:3084275 PMID:7893284 PMID:8017468 PMID:8944747 PMID:9006809 PMID:9223394 PMID:9822092 PMID:12048068 PMID:12782154 PMID:21640707 More...
|
|
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
|
|
G |
Apoc2 |
apolipoprotein C2 |
decreases expression multiple interactions |
ISO |
Bezafibrate results in decreased expression of APOC2 mRNA PPARA protein affects the reaction [Bezafibrate results in decreased expression of APOC2 mRNA]; PPARD protein affects the reaction [Bezafibrate results in decreased expression of APOC2 mRNA] |
CTD |
PMID:12782154 |
|
NCBI chr 1:79,329,429...79,334,397
Ensembl chr 1:79,329,428...79,334,476
|
|
G |
Apoc3 |
apolipoprotein C3 |
decreases expression multiple interactions |
ISO EXP |
Bezafibrate results in decreased expression of APOC3 mRNA PPARA protein affects the reaction [Bezafibrate results in decreased expression of APOC3 mRNA]; PPARD protein affects the reaction [Bezafibrate results in decreased expression of APOC3 mRNA] Bezafibrate results in decreased expression of APOC3 mRNA; Bezafibrate results in decreased expression of APOC3 protein |
CTD |
PMID:8847480 PMID:9041378 PMID:11164425 PMID:12782154 PMID:19124612 |
|
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
|
|
G |
Apoe |
apolipoprotein E |
multiple interactions decreases expression increases expression |
ISO EXP |
[Bezafibrate co-treated with Enalapril co-treated with Dipyridamole co-treated with Atorvastatin co-treated with Valsartan] results in decreased expression of APOE protein [Bezafibrate co-treated with Ethanolamine] results in decreased secretion of APOE protein Bezafibrate results in decreased expression of APOE protein Bezafibrate results in increased expression of APOE protein |
CTD |
PMID:8017468 PMID:8944747 PMID:9006809 PMID:19603250 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Arpp21 |
cAMP regulated phosphoprotein 21 |
increases expression |
ISO |
Bezafibrate results in increased expression of ARPP21 mRNA |
CTD |
PMID:18787029 |
|
NCBI chr 8:112,034,636...112,199,273
Ensembl chr 8:112,034,642...112,194,297
|
|
G |
Ascl2 |
achaete-scute family bHLH transcription factor 2 |
decreases expression |
ISO |
Bezafibrate results in decreased expression of ASCL2 mRNA |
CTD |
PMID:15708366 |
|
NCBI chr 1:198,148,999...198,151,406
Ensembl chr 1:198,148,999...198,151,406
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
EXP |
Bezafibrate results in decreased expression of BCL2 mRNA Bezafibrate inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2 protein] |
CTD |
PMID:12704018 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bmal1 |
basic helix-loop-helix ARNT like 1 |
multiple interactions |
ISO |
[CLOCK protein binds to BMAL1 protein] promotes the reaction [Bezafibrate results in increased expression of SERPINE1 mRNA] |
CTD |
PMID:20400680 |
|
NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:167,331,633...167,430,231
|
|
G |
Bmp2 |
bone morphogenetic protein 2 |
increases expression multiple interactions |
ISO |
Bezafibrate results in increased expression of BMP2 mRNA dorsomorphin inhibits the reaction [Bezafibrate results in increased expression of BMP2 mRNA]; GSK0660 inhibits the reaction [Bezafibrate results in increased expression of BMP2 mRNA] |
CTD |
PMID:21499286 |
|
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
increases expression |
ISO |
Bezafibrate results in increased expression of BNIP3 mRNA |
CTD |
PMID:17118139 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Btbd9 |
BTB domain containing 9 |
increases expression |
ISO |
Bezafibrate results in increased expression of BTBD9 mRNA |
CTD |
PMID:18787029 |
|
NCBI chr20:8,286,337...8,645,567
Ensembl chr20:8,288,711...8,643,960
|
|
G |
Car9 |
carbonic anhydrase 9 |
multiple interactions |
ISO |
Bezafibrate inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA] |
CTD |
PMID:34520103 |
|
NCBI chr 5:57,763,234...57,769,838
Ensembl chr 5:57,763,206...57,769,838
|
|
G |
Cat |
catalase |
increases activity multiple interactions increases expression |
EXP ISO |
Bezafibrate results in increased activity of CAT protein Bezafibrate inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in decreased expression of CAT mRNA] Bezafibrate inhibits the reaction [Streptozocin results in decreased activity of CAT protein]; Bezafibrate promotes the reaction [3-methylglutaric acid results in increased activity of CAT protein] Bezafibrate results in increased expression of CAT protein |
CTD |
PMID:2399535 PMID:17145126 PMID:18513333 PMID:20594415 PMID:32169667 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression multiple interactions |
ISO |
Bezafibrate results in decreased expression of CCL2 mRNA Bezafibrate inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of CCL2 mRNA] Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein] |
CTD |
PMID:16574099 PMID:18513333 PMID:32613381 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
multiple interactions |
ISO |
Bezafibrate inhibits the reaction [Palmitic Acid results in increased expression of CCL3 mRNA] |
CTD |
PMID:21745629 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions |
ISO |
Bezafibrate inhibits the reaction [Chenodeoxycholic Acid results in increased expression of CCL5 mRNA]; Bezafibrate inhibits the reaction [Chenodeoxycholic Acid results in increased expression of CCL5 protein]; Bezafibrate inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]; Bezafibrate inhibits the reaction [TNF protein results in increased expression of CCL5 protein] |
CTD |
PMID:12126966 PMID:12586603 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccn2 |
cellular communication network factor 2 |
multiple interactions |
ISO |
Bezafibrate inhibits the reaction [TGFB1 protein results in increased expression of CCN2 protein] |
CTD |
PMID:19429239 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccnb1 |
cyclin B1 |
increases expression |
ISO |
Bezafibrate results in increased expression of CCNB1 mRNA |
CTD |
PMID:15447978 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Cd36 |
CD36 molecule |
increases expression multiple interactions |
ISO EXP |
Bezafibrate results in increased expression of CD36 mRNA PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of CD36 mRNA]; PPARD protein affects the reaction [Bezafibrate results in increased expression of CD36 mRNA] |
CTD |
PMID:11473052 PMID:12759900 PMID:12782154 PMID:17118139 PMID:19124612 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cd40lg |
CD40 ligand |
multiple interactions decreases activity |
ISO |
[Bezafibrate co-treated with Medroxyprogesterone Acetate] results in decreased activity of CD40LG protein Bezafibrate results in decreased activity of CD40LG protein |
CTD |
PMID:18923439 |
|
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
increases expression |
ISO |
Bezafibrate results in increased expression of CDK4 mRNA |
CTD |
PMID:15447978 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Chmp4b |
charged multivesicular body protein 4B |
increases expression |
ISO |
Bezafibrate results in increased expression of CHMP4B mRNA |
CTD |
PMID:18787029 |
|
NCBI chr 3:143,170,859...143,211,376
Ensembl chr 3:143,170,902...143,210,844
|
|
G |
Clock |
clock circadian regulator |
multiple interactions |
ISO |
[CLOCK protein binds to BMAL1 protein] promotes the reaction [Bezafibrate results in increased expression of SERPINE1 mRNA]; CLOCK protein affects the reaction [Bezafibrate results in increased expression of SERPINE1 mRNA] |
CTD |
PMID:20400680 |
|
NCBI chr14:31,908,542...31,992,673
Ensembl chr14:31,908,566...31,990,400
|
|
G |
Clps |
colipase |
increases expression |
ISO |
Bezafibrate results in increased expression of CLPS mRNA |
CTD |
PMID:18787029 |
|
NCBI chr20:6,620,529...6,622,709
Ensembl chr20:6,620,529...6,622,689
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions increases expression |
ISO EXP |
Bezafibrate inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of COL1A1 mRNA] Bezafibrate results in increased expression of COL1A1 mRNA Bezafibrate inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA] |
CTD |
PMID:18513333 PMID:21499286 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
decreases expression multiple interactions increases expression |
ISO EXP |
Bezafibrate results in decreased expression of CPT1A mRNA [Butyrates co-treated with Bezafibrate] results in increased expression of CPT1A mRNA; [Sodium Glutamate co-treated with Bezafibrate] results in increased expression of CPT1A mRNA; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of CPT1A mRNA] Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Bezafibrate promotes the reaction [Oleic Acid results in increased expression of CPT1A mRNA] Bezafibrate inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of CPT1A mRNA] |
CTD |
PMID:11527545 PMID:16123366 PMID:16574099 PMID:18787029 PMID:19124612 PMID:19682441 PMID:21549692 PMID:21640707 PMID:21816645 PMID:22338096 PMID:24534255 PMID:26190035 PMID:32613381 More...
|
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Cpt1b |
carnitine palmitoyltransferase 1B |
increases expression multiple interactions |
ISO EXP |
Bezafibrate results in increased expression of CPT1B mRNA PPARA protein affects the reaction [Bezafibrate results in increased expression of CPT1B mRNA] |
CTD |
PMID:11056218 PMID:11473052 PMID:21324916 |
|
NCBI chr 7:120,491,354...120,500,833
Ensembl chr 7:120,491,354...120,500,404
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
increases expression increases activity multiple interactions |
EXP ISO |
Bezafibrate results in increased expression of CPT2 mRNA Bezafibrate results in increased activity of CPT2 protein [Bezafibrate results in increased activity of CPT2 protein] which results in increased abundance of Adenosine Triphosphate; [Oleic Acid co-treated with Bezafibrate] results in increased expression of CPT2 mRNA; Carnitine promotes the reaction [[Bezafibrate results in increased activity of CPT2 protein] which results in increased abundance of Adenosine Triphosphate] |
CTD |
PMID:16707586 PMID:21816645 PMID:24534255 |
|
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
|
|
G |
Crat |
carnitine O-acetyltransferase |
multiple interactions increases activity |
EXP |
etomoxir inhibits the reaction [Bezafibrate results in increased activity of CRAT protein] |
CTD |
PMID:3421940 PMID:8075222 PMID:9920142 |
|
NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
|
|
G |
Crebbp |
CREB binding protein |
multiple interactions |
ISO |
Bezafibrate affects the reaction [PPARA protein binds to CREBBP protein] |
CTD |
PMID:19263263 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Crem |
cAMP responsive element modulator |
decreases expression |
ISO |
Bezafibrate results in decreased expression of CREM mRNA |
CTD |
PMID:18787029 |
|
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
|
|
G |
Crot |
carnitine O-octanoyltransferase |
increases expression |
EXP |
Bezafibrate results in increased expression of CROT mRNA |
CTD |
PMID:17719200 |
|
NCBI chr 4:25,068,270...25,133,111
Ensembl chr 4:25,080,587...25,133,109
|
|
G |
Crp |
C-reactive protein |
decreases expression |
ISO |
Bezafibrate results in decreased expression of CRP protein |
CTD |
PMID:11893366 |
|
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Cyb5r3 |
cytochrome b5 reductase 3 |
affects expression |
EXP |
Bezafibrate affects the expression of CYB5R3 mRNA |
CTD |
PMID:17719200 |
|
NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
multiple interactions decreases expression |
ISO EXP |
Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CYBA mRNA] Bezafibrate results in decreased expression of CYBA mRNA Bezafibrate inhibits the reaction [Streptozocin results in increased expression of CYBA mRNA] |
CTD |
PMID:11172467 PMID:12967931 |
|
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cybb |
cytochrome b-245 beta chain |
increases expression |
ISO |
Bezafibrate results in increased expression of CYBB protein |
CTD |
PMID:20594415 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
decreases activity decreases expression multiple interactions |
ISO |
Bezafibrate results in decreased activity of CYP19A1 protein Bezafibrate results in decreased expression of CYP19A1 mRNA Bezafibrate inhibits the reaction [CYP19A1 gene mutant form results in decreased expression of ACADM mRNA]; Bezafibrate inhibits the reaction [CYP19A1 gene mutant form results in decreased expression of ACOX1 mRNA] |
CTD |
PMID:11929713 PMID:19539015 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression increases activity |
ISO EXP |
Bezafibrate results in increased expression of CYP1A1 mRNA Bezafibrate results in increased activity of CYP1A1 protein |
CTD |
PMID:9007043 PMID:15521013 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
Bezafibrate inhibits the reaction [Calcitriol results in increased expression of CYP24A1 mRNA] |
CTD |
PMID:19667161 |
|
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
decreases expression |
ISO |
Bezafibrate results in decreased expression of CYP2C8 protein |
CTD |
PMID:29960002 |
|
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
affects expression |
ISO |
Bezafibrate affects the expression of CYP2J2 protein |
CTD |
PMID:29960002 |
|
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
multiple interactions increases expression |
EXP |
Acetylcysteine promotes the reaction [Bezafibrate results in increased expression of CYP4A1 mRNA] |
CTD |
PMID:19647067 |
|
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
|
|
G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
increases expression |
EXP |
Bezafibrate results in increased expression of CYP4A3 mRNA |
CTD |
PMID:17719200 |
|
NCBI chr 5:129,097,571...129,115,488
Ensembl chr 5:129,097,926...129,115,463
|
|
G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
affects expression |
EXP |
Bezafibrate affects the expression of CYP4B1 mRNA |
CTD |
PMID:17719200 |
|
NCBI chr 5:129,139,019...129,176,860
Ensembl chr 5:129,139,038...129,156,348
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
decreases expression |
EXP |
Bezafibrate results in decreased expression of CYP51 mRNA |
CTD |
PMID:17719200 |
|
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
decreases activity decreases expression |
ISO EXP |
Bezafibrate results in decreased activity of CYP7A1 protein Bezafibrate results in decreased expression of CYP7A1 mRNA |
CTD |
PMID:2044640 PMID:14685799 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Dbi |
diazepam binding inhibitor |
increases expression |
ISO |
Bezafibrate results in increased expression of DBI mRNA |
CTD |
PMID:17118139 |
|
NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
affects expression |
EXP |
Bezafibrate affects the expression of DHCR7 mRNA |
CTD |
PMID:17719200 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dlk1 |
delta like non-canonical Notch ligand 1 |
increases expression |
EXP |
Bezafibrate results in increased expression of DLK1 mRNA |
CTD |
PMID:11473052 |
|
NCBI chr 6:128,410,216...128,417,518
Ensembl chr 6:128,410,316...128,417,522
|
|
G |
Dnajb6 |
DnaJ heat shock protein family (Hsp40) member B6 |
decreases expression |
ISO |
Bezafibrate results in decreased expression of DNAJB6 mRNA |
CTD |
PMID:18787029 |
|
NCBI chr 4:5,452,683...5,556,679
Ensembl chr 4:5,452,683...5,556,659
|
|
G |
Dnm1l |
dynamin 1-like |
multiple interactions |
EXP |
[Bezafibrate co-treated with 3-methylglutaric acid] results in increased expression of DNM1L protein |
CTD |
PMID:32169667 |
|
NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
|
|
G |
Dtnb |
dystrobrevin, beta |
decreases expression |
ISO |
Bezafibrate results in decreased expression of DTNB mRNA |
CTD |
PMID:18787029 |
|
NCBI chr 6:26,566,418...26,763,467
Ensembl chr 6:26,566,925...26,766,335
|
|
G |
Ech1 |
enoyl-CoA hydratase 1 |
increases expression |
ISO |
Bezafibrate results in increased expression of ECH1 mRNA |
CTD |
PMID:17118139 |
|
NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795
|
|
G |
Eci2 |
enoyl-CoA delta isomerase 2 |
increases expression |
EXP |
Bezafibrate results in increased expression of ECI2 mRNA |
CTD |
PMID:16707586 |
|
NCBI chr17:29,850,884...29,886,781
Ensembl chr17:29,870,391...29,886,781
|
|
G |
Edn1 |
endothelin 1 |
decreases expression multiple interactions |
ISO EXP |
Bezafibrate results in decreased expression of EDN1 protein Bezafibrate inhibits the reaction [Streptozocin results in increased expression of EDN1 mRNA] |
CTD |
PMID:11330878 PMID:12967931 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Ehhadh |
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase |
increases expression multiple interactions affects expression |
ISO EXP |
Bezafibrate results in increased expression of EHHADH mRNA; Bezafibrate results in increased expression of EHHADH protein PPARA protein affects the reaction [Bezafibrate results in increased expression of EHHADH protein]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of EHHADH mRNA] Bezafibrate affects the expression of EHHADH mRNA |
CTD |
PMID:12782154 PMID:17118139 PMID:17719200 PMID:19124612 |
|
NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
|
|
G |
Elovl6 |
ELOVL fatty acid elongase 6 |
multiple interactions |
ISO |
[Oleic Acid co-treated with Bezafibrate] results in increased expression of ELOVL6 mRNA |
CTD |
PMID:24534255 |
|
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
affects expression |
ISO |
Bezafibrate affects the expression of EPHX2 protein |
CTD |
PMID:29960002 |
|
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
multiple interactions decreases expression increases expression |
ISO EXP |
[Cisplatin co-treated with Bezafibrate] results in increased expression of FABP1 mRNA; Bezafibrate affects the localization of and results in increased expression of FABP1 protein; Bezafibrate inhibits the reaction [Cisplatin results in decreased expression of FABP1 protein] Bezafibrate results in decreased expression of FABP1 mRNA Bezafibrate results in increased expression of FABP1 mRNA Bezafibrate results in increased expression of FABP1 mRNA; Bezafibrate results in increased expression of FABP1 protein Butyrates promotes the reaction [Bezafibrate results in increased expression of FABP1 mRNA]; PPARA protein affects the reaction [Bezafibrate results in increased expression of FABP1 mRNA]; PPARA protein affects the reaction [Bezafibrate results in increased expression of FABP1 protein] 2-tetradecylglycidic acid inhibits the reaction [Bezafibrate results in increased expression of FABP1 protein]; Bezafibrate inhibits the reaction [Oleic Acid binds to FABP1 protein] |
CTD |
PMID:2328261 PMID:10191295 PMID:12782154 PMID:15708366 PMID:16574099 PMID:17118139 PMID:18368030 PMID:22338096 More...
|
|
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
|
|
G |
Fabp2 |
fatty acid binding protein 2 |
increases expression |
ISO |
Bezafibrate results in increased expression of FABP2 mRNA |
CTD |
PMID:17118139 |
|
NCBI chr 2:211,040,032...211,044,089
Ensembl chr 2:211,040,032...211,044,089
|
|
G |
Fabp3 |
fatty acid binding protein 3 |
decreases expression |
ISO |
Bezafibrate results in decreased expression of FABP3 mRNA |
CTD |
PMID:15708366 |
|
NCBI chr 5:142,651,962...142,658,707
Ensembl chr 5:142,651,956...142,658,718
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
increases expression multiple interactions |
ISO EXP |
Bezafibrate results in increased expression of FABP4 mRNA PPARA protein affects the reaction [Bezafibrate results in increased expression of FABP4 mRNA] |
CTD |
PMID:11473052 PMID:12759900 PMID:21324916 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fads1 |
fatty acid desaturase 1 |
increases activity |
EXP |
Bezafibrate results in increased activity of FADS1 protein |
CTD |
PMID:7606338 PMID:9032088 |
|
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
|
|
G |
Fads2 |
fatty acid desaturase 2 |
increases activity |
EXP |
Bezafibrate results in increased activity of FADS2 protein |
CTD |
PMID:7606338 |
|
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression multiple interactions |
ISO EXP |
Bezafibrate results in increased expression of FAS mRNA Bezafibrate inhibits the reaction [Dietary Fats results in increased expression of FAS mRNA] |
CTD |
PMID:16712844 PMID:26190035 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
affects expression |
ISO |
Bezafibrate affects the expression of FASLG protein modified form |
CTD |
PMID:15063428 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fasn |
fatty acid synthase |
affects expression increases expression decreases expression multiple interactions |
EXP ISO |
Bezafibrate affects the expression of FASN mRNA Bezafibrate results in increased expression of FASN mRNA; Bezafibrate results in increased expression of FASN protein Bezafibrate results in decreased expression of FASN mRNA; Bezafibrate results in decreased expression of FASN protein [Oleic Acid co-treated with Bezafibrate] results in increased expression of FASN mRNA |
CTD |
PMID:17118139 PMID:17719200 PMID:19124612 PMID:24534255 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
multiple interactions increases expression |
ISO |
[Bezafibrate promotes the reaction [PPARA protein binds to FGF21 promoter]] which results in decreased expression of HDAC3 protein; [Bezafibrate promotes the reaction [PPARA protein binds to FGF21 promoter]] which results in increased expression of POLR2A protein; Bezafibrate promotes the reaction [PPARA protein binds to FGF21 promoter]; Butyrates promotes the reaction [Bezafibrate results in increased expression of FGF21 mRNA]; Butyrates promotes the reaction [Bezafibrate results in increased expression of FGF21 protein]; PPARA protein promotes the reaction [Bezafibrate results in increased expression of FGF21 mRNA] Bezafibrate results in increased expression of FGF21 mRNA; Bezafibrate results in increased expression of FGF21 protein |
CTD |
PMID:18787029 PMID:20854792 PMID:21720023 PMID:22338096 |
|
NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
EXP |
Bezafibrate inhibits the reaction [TGFB1 protein results in increased expression of FN1 mRNA] |
CTD |
PMID:18513333 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [[FOS protein binds to JUN protein modified form] which binds to SPP1 promoter]]; Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of FOS mRNA]; Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of FOS protein] |
CTD |
PMID:17360982 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
multiple interactions |
ISO |
[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Bezafibrate promotes the reaction [TNF protein inhibits the reaction [FSHB protein results in increased secretion of Estradiol]]]; Bezafibrate promotes the reaction [TNF protein inhibits the reaction [FSHB protein results in increased secretion of Estradiol]]; Bezafibrate promotes the reaction [TNF protein results in decreased susceptibility to FSHB protein] |
CTD |
PMID:21734263 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
multiple interactions |
EXP |
Bezafibrate inhibits the reaction [3-methylglutaric acid results in decreased activity of G6PD protein]; Bezafibrate inhibits the reaction [etomoxir results in increased activity of G6PD protein] |
CTD |
PMID:3421940 PMID:32169667 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
decreases expression increases expression multiple interactions |
ISO |
Bezafibrate results in decreased expression of GPAM mRNA; Bezafibrate results in decreased expression of GPAM protein Bezafibrate results in increased expression of GPAM mRNA; Bezafibrate results in increased expression of GPAM protein PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of GPAM mRNA] |
CTD |
PMID:19124612 |
|
NCBI chr 1:254,106,323...254,170,755
Ensembl chr 1:254,106,331...254,142,639
|
|
G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 |
increases expression multiple interactions |
ISO |
Bezafibrate results in increased expression of GPD1 mRNA Bucladesine promotes the reaction [Bezafibrate results in increased expression of GPD1 mRNA] |
CTD |
PMID:1976021 |
|
NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
Bezafibrate promotes the reaction [Sodium Glutamate results in increased expression of GPT protein] |
CTD |
PMID:21549692 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions decreases activity |
EXP |
Bezafibrate inhibits the reaction [Streptozocin results in decreased activity of GSR protein] Bezafibrate results in decreased activity of GSR protein |
CTD |
PMID:17145126 PMID:17710547 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
increases expression |
ISO |
Bezafibrate results in increased expression of HADHA mRNA |
CTD |
PMID:17118139 |
|
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
|
|
G |
Hadhb |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta |
increases expression |
ISO |
Bezafibrate results in increased expression of HADHB mRNA |
CTD |
PMID:17118139 |
|
NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869
|
|
G |
Hdac3 |
histone deacetylase 3 |
multiple interactions |
ISO |
[Bezafibrate promotes the reaction [PPARA protein binds to FGF21 promoter]] which results in decreased expression of HDAC3 protein |
CTD |
PMID:22338096 |
|
NCBI chr18:29,770,637...29,789,850
Ensembl chr18:29,770,636...29,793,856
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
decreases activity increases activity |
EXP ISO |
Bezafibrate results in decreased activity of HMGCR protein Bezafibrate results in increased activity of HMGCR protein |
CTD |
PMID:2044640 PMID:2907502 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 |
multiple interactions increases expression |
ISO |
Butyrates promotes the reaction [Bezafibrate results in increased expression of HMGCS2 mRNA] |
CTD |
PMID:18787029 PMID:22338096 |
|
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
|
|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
decreases activity decreases expression |
ISO |
Bezafibrate results in decreased activity of HSD11B1 protein Bezafibrate results in decreased expression of HSD11B1 mRNA |
CTD |
PMID:17190905 |
|
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
|
|
G |
Hsd17b4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
increases expression |
ISO |
Bezafibrate results in increased expression of HSD17B4 mRNA |
CTD |
PMID:17118139 |
|
NCBI chr18:43,328,903...43,417,950
Ensembl chr18:43,328,824...43,417,952
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
[Vitamin E co-treated with Bezafibrate] results in decreased expression of ICAM1 protein modified form |
CTD |
PMID:14602771 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
EXP |
Bezafibrate results in decreased susceptibility to [IFNG protein co-treated with IL1B protein] |
CTD |
PMID:20631892 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf1 |
insulin-like growth factor 1 |
decreases expression |
ISO |
Bezafibrate results in decreased expression of IGF1 protein |
CTD |
PMID:10716467 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
EXP |
Bezafibrate inhibits the reaction [Aldosterone results in increased expression of IL18 mRNA] |
CTD |
PMID:18660453 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions decreases expression increases expression |
ISO EXP |
Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Bezafibrate promotes the reaction [IL1B protein results in increased expression of NPHS1 mRNA] Bezafibrate inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of IL1B mRNA] Bezafibrate results in decreased expression of IL1B mRNA Bezafibrate results in decreased susceptibility to [IFNG protein co-treated with IL1B protein] Bezafibrate results in decreased expression of IL1B protein Bezafibrate results in increased expression of IL1B protein |
CTD |
PMID:12657956 PMID:12704018 PMID:16288986 PMID:16574099 PMID:18513333 PMID:20631892 PMID:32613381 More...
|
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions decreases expression |
ISO EXP |
Bezafibrate affects the susceptibility to [Lipopolysaccharides results in increased secretion of IL6 protein]; Bezafibrate inhibits the reaction [IL6 protein results in increased expression of SPP1 mRNA] Bezafibrate inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of IL6 mRNA] Bezafibrate results in decreased expression of IL6 mRNA Bezafibrate results in decreased expression of IL6 protein |
CTD |
PMID:11893366 PMID:12657956 PMID:16574099 PMID:17360982 PMID:18513333 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins1 |
insulin 1 |
decreases expression multiple interactions |
EXP |
Bezafibrate results in decreased expression of INS1 mRNA Diazoxide inhibits the reaction [Bezafibrate results in decreased expression of INS1 mRNA] |
CTD |
PMID:11527545 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Ins2 |
insulin 2 |
multiple interactions decreases expression |
ISO |
[Bezafibrate binds to and results in increased activity of PPARA protein] which results in decreased expression of INS protein; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Bezafibrate inhibits the reaction [[Oleic Acid co-treated with INS protein] results in increased expression of SERPINE1 mRNA]; Bezafibrate inhibits the reaction [[Oleic Acid co-treated with INS protein] results in increased expression of SERPINE1 protein]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein] Bezafibrate results in decreased expression of INS protein |
CTD |
PMID:2209320 PMID:11292061 PMID:20404010 PMID:32613381 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Insig1 |
insulin induced gene 1 |
increases expression |
ISO |
Bezafibrate results in increased expression of INSIG1 mRNA |
CTD |
PMID:17118139 PMID:19124612 |
|
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [[FOS protein binds to JUN protein modified form] which binds to SPP1 promoter]]; Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of JUN mRNA]; Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of JUN protein] |
CTD |
PMID:17360982 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Ldha |
lactate dehydrogenase A |
increases expression |
EXP |
Bezafibrate results in increased expression of LDHA protein |
CTD |
PMID:8632003 |
|
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Lep |
leptin |
decreases expression multiple interactions |
ISO EXP |
Bezafibrate results in decreased expression of LEP Bezafibrate inhibits the reaction [Lipopolysaccharides results in increased expression of LEP protein] Bezafibrate results in decreased expression of LEP mRNA Bezafibrate inhibits the reaction [Sodium Glutamate results in increased expression of LEP protein] |
CTD |
PMID:10726910 PMID:11216866 PMID:11473052 PMID:17379010 PMID:21549692 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lgals3 |
galectin 3 |
increases expression |
ISO |
Bezafibrate results in increased expression of LGALS3 mRNA |
CTD |
PMID:17118139 |
|
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
|
|
G |
Lipc |
lipase C, hepatic type |
increases activity |
ISO |
Bezafibrate results in increased activity of LIPC protein |
CTD |
PMID:3084275 |
|
NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
|
|
G |
Lpl |
lipoprotein lipase |
increases expression multiple interactions increases activity |
ISO EXP |
Bezafibrate results in increased expression of LPL mRNA PPARA protein affects the reaction [Bezafibrate results in increased expression of LPL mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of LPL mRNA] Bezafibrate results in increased activity of LPL protein [Bezafibrate results in increased activity of LPL protein] which results in decreased abundance of Triglycerides; Bezafibrate inhibits the reaction [Lipopolysaccharides results in decreased expression of LPL mRNA] |
CTD |
PMID:2907502 PMID:8147947 PMID:8593127 PMID:9006809 PMID:11164425 PMID:12782154 PMID:17379010 PMID:19124612 More...
|
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Ly6d |
lymphocyte antigen 6 family member D |
increases expression |
ISO |
Bezafibrate results in increased expression of LY6D mRNA |
CTD |
PMID:17118139 |
|
NCBI chr 7:106,643,225...106,644,733
Ensembl chr 7:106,643,232...106,644,733
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
EXP |
Bezafibrate results in decreased phosphorylation of and results in decreased activity of MAPK1 protein |
CTD |
PMID:11687581 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
EXP |
Bezafibrate results in decreased phosphorylation of and results in decreased activity of MAPK3 protein |
CTD |
PMID:11687581 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mfn1 |
mitofusin 1 |
multiple interactions |
EXP |
Bezafibrate inhibits the reaction [3-methylglutaric acid results in increased expression of MFN1 protein] |
CTD |
PMID:32169667 |
|
NCBI chr 2:115,313,380...115,359,651
Ensembl chr 2:115,313,401...115,359,640
|
|
G |
Mgll |
monoglyceride lipase |
increases expression |
ISO |
Bezafibrate results in increased expression of MGLL mRNA |
CTD |
PMID:17118139 |
|
NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
increases expression |
ISO |
Bezafibrate results in increased expression of MGMT mRNA |
CTD |
PMID:15447978 |
|
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mpeg1 |
macrophage expressed 1 |
decreases expression |
ISO |
Bezafibrate results in decreased expression of MPEG1 mRNA |
CTD |
PMID:18787029 |
|
NCBI chr 1:209,452,176...209,456,692
Ensembl chr 1:209,452,133...209,458,855
|
|
G |
Mpg |
N-methylpurine-DNA glycosylase |
increases expression |
ISO |
Bezafibrate results in increased expression of MPG mRNA |
CTD |
PMID:15447978 |
|
NCBI chr10:15,396,246...15,402,528
Ensembl chr10:15,395,782...15,402,520
|
|
G |
Mttp |
microsomal triglyceride transfer protein |
increases expression decreases expression multiple interactions |
ISO |
Bezafibrate results in increased expression of MTTP mRNA Bezafibrate results in decreased expression of MTTP mRNA PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of MTTP mRNA] |
CTD |
PMID:19124612 |
|
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
multiple interactions |
ISO |
Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NCF1 protein] |
CTD |
PMID:11172467 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Ncoa1 |
nuclear receptor coactivator 1 |
multiple interactions |
ISO |
Bezafibrate promotes the reaction [PPARA protein binds to NCOA1 protein] |
CTD |
PMID:19263263 |
|
NCBI chr 6:27,232,609...27,507,992
Ensembl chr 6:27,232,611...27,475,664
|
|
G |
Ncoa2 |
nuclear receptor coactivator 2 |
multiple interactions |
ISO |
Bezafibrate promotes the reaction [PPARA protein binds to NCOA2 protein] |
CTD |
PMID:19263263 |
|
NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:5,835,706...6,067,451
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases activity |
ISO |
Bezafibrate results in increased activity of NFE2L2 protein |
CTD |
PMID:30114225 PMID:30203046 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions decreases expression |
ISO |
Bezafibrate inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of NFKB1 mRNA] Bezafibrate results in decreased expression of NFKB1 mRNA |
CTD |
PMID:16574099 PMID:18513333 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nos3 |
nitric oxide synthase 3 |
multiple interactions increases phosphorylation |
ISO |
[Bezafibrate results in increased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide; dorsomorphin inhibits the reaction [[Bezafibrate results in increased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide]; dorsomorphin inhibits the reaction [Bezafibrate results in increased phosphorylation of NOS3 protein] |
CTD |
PMID:21499286 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nox4 |
NADPH oxidase 4 |
increases expression multiple interactions |
ISO EXP |
Bezafibrate results in increased expression of NOX4 protein Bezafibrate inhibits the reaction [Streptozocin results in increased expression of NOX4 mRNA] |
CTD |
PMID:16979161 PMID:20594415 |
|
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
|
|
G |
Npy |
neuropeptide Y |
increases expression |
ISO |
Bezafibrate results in increased expression of NPY mRNA |
CTD |
PMID:18787029 |
|
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
increases expression multiple interactions |
ISO |
Bezafibrate results in increased expression of NR0B2 mRNA PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of NR0B2 mRNA] |
CTD |
PMID:19124612 |
|
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
|
|
G |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
increases expression |
ISO |
Bezafibrate results in increased expression of NR1H2 mRNA |
CTD |
PMID:19201410 |
|
NCBI chr 1:95,041,967...95,047,358
Ensembl chr 1:95,041,967...95,047,377
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
multiple interactions increases expression affects response to substance |
ISO EXP |
[Bezafibrate binds to and results in increased activity of PPARA protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased expression of ABCA1 mRNA]; [Bezafibrate binds to and results in increased activity of PPARA protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased transport of Cholesterol]; [Bezafibrate binds to and results in increased activity of PPARA protein] which results in increased expression of NR1H3 mRNA; NR1H3 protein affects the reaction [Bezafibrate results in increased expression of PPARA mRNA] Bezafibrate results in increased expression of NR1H3 mRNA NR1H3 protein affects the susceptibility to Bezafibrate PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of NR1H3 mRNA] Bezafibrate inhibits the reaction [Dietary Fats results in increased expression of NR1H3 mRNA] |
CTD |
PMID:12595494 PMID:19124612 PMID:19201410 PMID:26190035 |
|
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions increases expression |
ISO |
PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of NR1H4 mRNA] [Oleic Acid co-treated with Bezafibrate] results in increased expression of NR1H4 mRNA |
CTD |
PMID:15447978 PMID:19124612 PMID:24534255 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
Bezafibrate binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:20024649 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
increases expression |
EXP |
Bezafibrate results in increased expression of NR1I3 mRNA |
CTD |
PMID:20208394 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nthl1 |
nth-like DNA glycosylase 1 |
increases expression |
ISO |
Bezafibrate results in increased expression of NTHL1 mRNA |
CTD |
PMID:15447978 |
|
NCBI chr10:13,655,791...13,661,958
Ensembl chr10:13,655,785...13,661,957
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
increases expression |
ISO |
Bezafibrate results in increased expression of OGG1 mRNA |
CTD |
PMID:15447978 |
|
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
|
|
G |
Pc |
pyruvate carboxylase |
increases expression |
EXP |
Bezafibrate results in increased expression of PC mRNA |
CTD |
PMID:11527545 |
|
NCBI chr 1:201,799,374...201,898,412
Ensembl chr 1:201,804,267...201,898,380
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Bezafibrate] results in decreased expression of PCK1 mRNA |
CTD |
PMID:21549692 |
|
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
|
|
G |
Pcna |
proliferating cell nuclear antigen |
increases expression |
ISO EXP |
Bezafibrate results in increased expression of PCNA mRNA Bezafibrate results in increased expression of PCNA protein |
CTD |
PMID:9007043 PMID:15447978 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pcsk9 |
proprotein convertase subtilisin/kexin type 9 |
increases expression |
ISO |
Bezafibrate results in increased expression of PCSK9 protein |
CTD |
PMID:21411093 |
|
NCBI chr 5:121,211,278...121,233,688
Ensembl chr 5:121,211,278...121,233,688
|
|
G |
Pdha1 |
pyruvate dehydrogenase E1 subunit alpha 1 |
increases expression |
EXP |
Bezafibrate results in increased expression of PDHA1 mRNA |
CTD |
PMID:11527545 |
|
NCBI chr X:34,700,481...34,714,309
Ensembl chr X:34,700,409...34,714,311
|
|
G |
Pdk2 |
pyruvate dehydrogenase kinase 2 |
increases expression multiple interactions |
ISO |
Bezafibrate results in increased expression of PDK2 mRNA PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of PDK2 mRNA] |
CTD |
PMID:19124612 |
|
NCBI chr10:79,972,550...79,987,074
Ensembl chr10:79,972,556...79,987,085
|
|
G |
Pdk4 |
pyruvate dehydrogenase kinase 4 |
increases expression multiple interactions |
ISO |
Bezafibrate results in increased expression of PDK4 mRNA; Bezafibrate results in increased expression of PDK4 protein MK-886 inhibits the reaction [Bezafibrate results in increased expression of PDK4 mRNA]; MK-886 inhibits the reaction [Bezafibrate results in increased expression of PDK4 protein] PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of PDK4 mRNA] |
CTD |
PMID:17118139 PMID:19124612 PMID:19683050 PMID:21720023 |
|
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
|
|
G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
multiple interactions decreases expression |
EXP |
Diazoxide inhibits the reaction [Bezafibrate results in decreased expression of PDX1 mRNA] |
CTD |
PMID:11527545 |
|
NCBI chr12:7,757,865...7,763,064
Ensembl chr12:7,757,865...7,763,064
|
|
G |
Plin2 |
perilipin 2 |
multiple interactions |
ISO |
Bezafibrate promotes the reaction [Oleic Acid results in increased expression of PLIN2 mRNA] |
CTD |
PMID:24534255 |
|
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
|
|
G |
Plin4 |
perilipin 4 |
multiple interactions |
ISO |
Bezafibrate promotes the reaction [Oleic Acid results in increased expression of PLIN4 mRNA] |
CTD |
PMID:24534255 |
|
NCBI chr 9:929,168...938,062
Ensembl chr 9:929,176...938,056
|
|
G |
Pltp |
phospholipid transfer protein |
decreases activity multiple interactions |
ISO |
Bezafibrate results in decreased activity of PLTP protein [Bezafibrate results in decreased activity of PLTP protein] affects the reaction [Bezafibrate results in decreased abundance of Fatty Acids, Nonesterified] |
CTD |
PMID:12754275 |
|
NCBI chr 3:153,574,825...153,592,647
Ensembl chr 3:153,574,825...153,592,647
|
|
G |
Pnliprp2 |
pancreatic lipase related protein 2 |
increases expression |
ISO |
Bezafibrate results in increased expression of PNLIPRP2 mRNA |
CTD |
PMID:18787029 |
|
NCBI chr 1:257,897,766...257,916,434
Ensembl chr 1:257,897,766...257,916,434
|
|
G |
Polr2a |
RNA polymerase II subunit A |
multiple interactions |
ISO |
[Bezafibrate promotes the reaction [PPARA protein binds to FGF21 promoter]] which results in increased expression of POLR2A protein |
CTD |
PMID:22338096 |
|
NCBI chr10:54,452,438...54,478,486
Ensembl chr10:54,452,441...54,478,455
|
|
G |
Pomc |
proopiomelanocortin |
decreases expression |
ISO |
Bezafibrate results in decreased expression of POMC mRNA |
CTD |
PMID:18787029 |
|
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
Por |
cytochrome p450 oxidoreductase |
increases activity |
EXP |
Bezafibrate results in increased activity of POR protein |
CTD |
PMID:7606338 |
|
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions increases response to substance increases activity increases expression affects binding decreases expression affects response to substance |
ISO EXP |
[Bezafibrate binds to and results in increased activity of PPARA protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased expression of ABCA1 mRNA]; [Bezafibrate binds to and results in increased activity of PPARA protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased transport of Cholesterol]; [Bezafibrate binds to and results in increased activity of PPARA protein] promotes the reaction [APOA1 protein results in increased transport of Cholesterol]; [Bezafibrate binds to and results in increased activity of PPARA protein] which results in decreased abundance of Glucose; [Bezafibrate binds to and results in increased activity of PPARA protein] which results in decreased abundance of Triglycerides; [Bezafibrate binds to and results in increased activity of PPARA protein] which results in decreased expression of INS protein; [Bezafibrate binds to and results in increased activity of PPARA protein] which results in increased abundance of 3-Hydroxybutyric Acid; [Bezafibrate binds to and results in increased activity of PPARA protein] which results in increased abundance of Ketones; [Bezafibrate binds to and results in increased activity of PPARA protein] which results in increased expression of ABCA1 mRNA; [Bezafibrate binds to and results in increased activity of PPARA protein] which results in increased expression of NR1H3 mRNA; [Bezafibrate binds to and results in increased activity of PPARA protein] which results in increased oxidation of Linoleic Acid; Bezafibrate affects the reaction [PPARA protein binds to CREBBP protein]; Bezafibrate binds to and results in increased activity of PPARA protein; Bezafibrate promotes the reaction [PPARA protein binds to NCOA1 protein]; Bezafibrate promotes the reaction [PPARA protein binds to NCOA2 protein]; Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]; Calcitriol promotes the reaction [Bezafibrate results in increased expression of PPARA mRNA]; cerivastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]; Cholesterol inhibits the reaction [cerivastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]]; Farnesol inhibits the reaction [cerivastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]]; fluvastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]; geranylgeraniol inhibits the reaction [cerivastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]]; Mevalonic Acid inhibits the reaction [cerivastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]]; MK-886 inhibits the reaction [Bezafibrate results in increased expression of PPARA mRNA]; NR1H3 protein affects the reaction [Bezafibrate results in increased expression of PPARA mRNA]; pitavastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]; PPARA protein affects the reaction [Bezafibrate affects the localization of ABCB4 protein]; PPARA protein affects the reaction [Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SPP1 mRNA]]; SREBF1 protein inhibits the reaction [cerivastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]] PPARA protein results in increased susceptibility to Bezafibrate [[Bezafibrate results in increased activity of PPARA protein] which results in increased uptake of and results in increased oxidation of Fatty Acids] which results in decreased abundance of Triglycerides; [Bezafibrate binds to and results in increased activity of PPARA protein] which results in increased oxidation of Fatty Acids; [Bezafibrate co-treated with Sodium Glutamate] results in increased expression of PPARA mRNA; [Bezafibrate promotes the reaction [PPARA protein binds to FGF21 promoter]] which results in decreased expression of HDAC3 protein; [Bezafibrate promotes the reaction [PPARA protein binds to FGF21 promoter]] which results in increased expression of POLR2A protein; [Bezafibrate results in increased activity of PPARA protein] which results in increased expression of TRIB3 mRNA; [Bezafibrate results in increased activity of PPARA protein] which results in increased uptake of and results in increased oxidation of Fatty Acids; Bezafibrate promotes the reaction [PPARA protein binds to FGF21 promoter]; Bezafibrate promotes the reaction [PPARA protein binds to SERPINE1 promoter]; PPARA protein affects the reaction [Bezafibrate results in decreased expression of APOB mRNA alternative form]; PPARA protein affects the reaction [Bezafibrate results in decreased expression of APOC2 mRNA]; PPARA protein affects the reaction [Bezafibrate results in decreased expression of APOC3 mRNA]; PPARA protein affects the reaction [Bezafibrate results in increased abundance of Lipid Peroxides]; PPARA protein affects the reaction [Bezafibrate results in increased expression of ACADL mRNA]; PPARA protein affects the reaction [Bezafibrate results in increased expression of ACADL protein]; PPARA protein affects the reaction [Bezafibrate results in increased expression of ACADVL mRNA]; PPARA protein affects the reaction [Bezafibrate results in increased expression of ACADVL protein]; PPARA protein affects the reaction [Bezafibrate results in increased expression of ACOX1 mRNA]; PPARA protein affects the reaction [Bezafibrate results in increased expression of CPT1B mRNA]; PPARA protein affects the reaction [Bezafibrate results in increased expression of CYP4A14 mRNA]; PPARA protein affects the reaction [Bezafibrate results in increased expression of EHHADH protein]; PPARA protein affects the reaction [Bezafibrate results in increased expression of FABP1 mRNA]; PPARA protein affects the reaction [Bezafibrate results in increased expression of FABP1 protein]; PPARA protein affects the reaction [Bezafibrate results in increased expression of FABP4 mRNA]; PPARA protein affects the reaction [Bezafibrate results in increased expression of LPL mRNA]; PPARA protein affects the reaction [Bezafibrate results in increased expression of PPARG mRNA]; PPARA protein affects the reaction [Bezafibrate results in increased expression of SCD1 mRNA]; PPARA protein affects the reaction [Bezafibrate results in increased expression of SERPINE1 mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in decreased expression of SREBF1 mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of ACAA1A mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of ACACA mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of ACACA protein]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of ACACB mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of ACADM mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of ACSL1 mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of CD36 mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of CPT1A mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of EHHADH mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of GPAM mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of LPL mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of MTTP mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of NR0B2 mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of NR1H3 mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of NR1H4 mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of PDK2 mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of PDK4 mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of SCAP mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of SCAP protein]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of SLC27A1 mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of SLC27A2 mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of SREBF1 protein]; PPARA protein inhibits the reaction [Bezafibrate results in increased expression of SERPINE1 mRNA]; PPARA protein promotes the reaction [Bezafibrate results in increased expression of CYP4A10 mRNA]; PPARA protein promotes the reaction [Bezafibrate results in increased expression of FGF21 mRNA] Bezafibrate results in increased expression of PPARA; Bezafibrate results in increased expression of PPARA mRNA; Bezafibrate results in increased expression of PPARA protein Bezafibrate binds to PPARA protein Bezafibrate results in decreased expression of PPARA mRNA [Bezafibrate results in increased activity of PPARA protein] which results in increased activity of SMPD1 protein; Bezafibrate results in increased activity of PPARA protein PPARA protein affects the susceptibility to Bezafibrate [Bezafibrate binds to and results in increased activity of PPARA protein] which results in decreased susceptibility to Palmitates; [Bezafibrate binds to and results in increased activity of PPARA protein] which results in increased abundance of Nitric Oxide; [Bezafibrate binds to and results in increased activity of PPARA protein] which results in increased expression of UCP2 mRNA; [Bezafibrate results in increased activity of PPARA protein] which results in decreased abundance of sphingosine 1-phosphate; [Bezafibrate results in increased activity of PPARA protein] which results in decreased activity of SMPD2 protein; [Bezafibrate results in increased activity of PPARA protein] which results in increased abundance of Ceramides; Bezafibrate binds to and results in increased activity of PPARA protein; Bezafibrate inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA]; Bezafibrate inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARA protein]; Bezafibrate inhibits the reaction [Dietary Fats results in decreased expression of PPARA protein]; Bezafibrate inhibits the reaction [Streptozocin results in decreased expression of PPARA mRNA] |
CTD |
PMID:9836514 PMID:10585473 PMID:11056218 PMID:11172467 PMID:11341955 PMID:11519881 PMID:11527545 PMID:11579993 PMID:11779144 PMID:12401884 PMID:12595494 PMID:12782154 PMID:12967931 PMID:15258199 PMID:15447978 PMID:15491415 PMID:16054168 PMID:17360982 PMID:18024222 PMID:19124612 PMID:19201410 PMID:19263263 PMID:19593819 PMID:19667161 PMID:19682441 PMID:19683050 PMID:20040336 PMID:20400680 PMID:20404010 PMID:20594415 PMID:20854792 PMID:21209018 PMID:21324916 PMID:21549692 PMID:21640707 PMID:21687928 PMID:22338096 PMID:23843199 PMID:24759758 PMID:25689681 PMID:26190035 PMID:27665777 PMID:30203046 PMID:31472229 PMID:31538121 More...
|
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
affects binding increases activity multiple interactions increases expression decreases expression |
ISO EXP |
Bezafibrate binds to PPARB protein; Bezafibrate binds to PPARD protein Bezafibrate results in increased activity of PPARD protein Bezafibrate results in increased activity of [PPARD protein binds to RXRA protein]; Calcitriol promotes the reaction [Bezafibrate results in increased expression of PPARD mRNA] Bezafibrate results in increased expression of PPARD mRNA; Bezafibrate results in increased expression of PPARD protein Bezafibrate inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARB mRNA] Bezafibrate results in increased expression of PPARD; Bezafibrate results in increased expression of PPARD mRNA PPARD protein affects the reaction [Bezafibrate results in decreased expression of APOB mRNA alternative form]; PPARD protein affects the reaction [Bezafibrate results in decreased expression of APOC2 mRNA]; PPARD protein affects the reaction [Bezafibrate results in decreased expression of APOC3 mRNA]; PPARD protein affects the reaction [Bezafibrate results in increased expression of CD36 mRNA] Bezafibrate results in decreased expression of PPARD mRNA |
CTD |
PMID:10585473 PMID:11172467 PMID:11779144 PMID:12782154 PMID:19124612 PMID:19201410 PMID:19214135 PMID:19667161 PMID:21687928 PMID:21816645 PMID:23843199 PMID:24759758 PMID:26190035 More...
|
|
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions decreases expression increases activity increases expression affects binding |
ISO EXP |
[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Bezafibrate promotes the reaction [TNF protein inhibits the reaction [FSHB protein results in increased secretion of Estradiol]]]; Bezafibrate results in increased activity of [PPARG protein alternative form binds to RXRA protein]; PPARG protein affects the reaction [Bezafibrate results in increased susceptibility to TNF protein] Bezafibrate results in decreased expression of PPARG mRNA Bezafibrate results in increased activity of PPARG protein PPARA protein affects the reaction [Bezafibrate results in increased expression of PPARG mRNA] Bezafibrate inhibits the reaction [3-methylglutaric acid results in increased expression of PPARG protein]; Bezafibrate inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA] Bezafibrate binds to PPARG protein |
CTD |
PMID:11473052 PMID:11779144 PMID:12401884 PMID:12967931 PMID:15708366 PMID:19201410 PMID:21324916 PMID:21734263 PMID:23843199 PMID:24759758 PMID:32169667 More...
|
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
increases expression |
ISO |
Bezafibrate results in increased expression of PPARGC1A mRNA |
CTD |
PMID:17275789 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Psmc3ip |
PSMC3 interacting protein |
decreases expression |
ISO |
Bezafibrate results in decreased expression of PSMC3IP mRNA |
CTD |
PMID:18787029 |
|
NCBI chr10:86,024,281...86,027,928
Ensembl chr10:86,023,950...86,027,423
|
|
G |
Rarb |
retinoic acid receptor, beta |
decreases expression |
EXP |
Bezafibrate results in decreased expression of RARB mRNA |
CTD |
PMID:11519881 PMID:11579993 |
|
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
Bezafibrate inhibits the reaction [Aldosterone results in increased activity of RELA protein] |
CTD |
PMID:18660453 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Reln |
reelin |
increases expression |
ISO |
Bezafibrate results in increased expression of RELN mRNA |
CTD |
PMID:18787029 |
|
NCBI chr 4:12,736,177...13,162,956
Ensembl chr 4:12,736,130...13,162,211
|
|
G |
Rida |
reactive intermediate imine deaminase A homolog |
multiple interactions |
EXP |
[Bezafibrate co-treated with Sunflower Oil] results in increased expression of RIDA protein |
CTD |
PMID:16843601 |
|
NCBI chr 7:65,691,429...65,705,257
Ensembl chr 7:65,691,435...65,705,716
|
|
G |
Rmnd1 |
required for meiotic nuclear division 1 homolog |
decreases expression |
ISO |
Bezafibrate results in decreased expression of RMND1 mRNA |
CTD |
PMID:18787029 |
|
NCBI chr 1:40,859,829...40,894,376
Ensembl chr 1:40,859,829...40,894,314
|
|
G |
Runx2 |
RUNX family transcription factor 2 |
increases expression multiple interactions |
ISO |
Bezafibrate results in increased expression of RUNX2 mRNA dorsomorphin inhibits the reaction [Bezafibrate results in increased expression of RUNX2 mRNA]; GSK0660 inhibits the reaction [Bezafibrate results in increased expression of RUNX2 mRNA] |
CTD |
PMID:21499286 |
|
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
|
|
G |
Rxra |
retinoid X receptor alpha |
multiple interactions affects binding |
ISO |
Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]; Bezafibrate results in increased activity of [PPARD protein binds to RXRA protein]; Bezafibrate results in increased activity of [PPARG protein alternative form binds to RXRA protein]; cerivastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]; Cholesterol inhibits the reaction [cerivastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]]; Farnesol inhibits the reaction [cerivastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]]; fluvastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]; geranylgeraniol inhibits the reaction [cerivastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]]; Mevalonic Acid inhibits the reaction [cerivastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]]; pitavastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]; SREBF1 protein inhibits the reaction [cerivastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]] Bezafibrate binds to RXRA protein |
CTD |
PMID:11779144 PMID:23843199 |
|
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
Rxrb |
retinoid X receptor beta |
affects binding |
ISO |
Bezafibrate binds to RXRB protein |
CTD |
PMID:23843199 |
|
NCBI chr20:4,816,813...4,823,267
Ensembl chr20:4,816,815...4,828,773
|
|
G |
Rxrg |
retinoid X receptor gamma |
affects binding |
ISO |
Bezafibrate binds to RXRG protein |
CTD |
PMID:23843199 |
|
NCBI chr13:79,743,430...79,785,173
Ensembl chr13:79,743,563...79,785,167
|
|
G |
Scap |
SREBF chaperone |
decreases expression increases expression multiple interactions |
ISO |
Bezafibrate results in decreased expression of SCAP mRNA; Bezafibrate results in decreased expression of SCAP protein Bezafibrate results in increased expression of SCAP mRNA; Bezafibrate results in increased expression of SCAP protein PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of SCAP mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of SCAP protein] |
CTD |
PMID:19124612 |
|
NCBI chr 8:110,306,026...110,360,677
Ensembl chr 8:110,306,031...110,360,666
|
|
G |
Scd |
stearoyl-CoA desaturase |
decreases expression multiple interactions increases expression increases activity |
ISO EXP |
Bezafibrate results in decreased expression of SCD1 mRNA PPARA protein affects the reaction [Bezafibrate results in increased expression of SCD1 mRNA] [Oleic Acid co-treated with Bezafibrate] results in increased expression of SCD1 mRNA; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA] Bezafibrate results in increased activity of SCD protein; Bezafibrate results in increased activity of SCD1 protein |
CTD |
PMID:7606338 PMID:11172741 PMID:12782154 PMID:19124612 PMID:24534255 PMID:32613381 More...
|
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Scd2 |
stearoyl-Coenzyme A desaturase 2 |
increases expression |
ISO |
Bezafibrate results in increased expression of SCD mRNA |
CTD |
PMID:17118139 |
|
NCBI chr 1:243,169,171...243,182,231
Ensembl chr 1:243,169,236...243,182,232
|
|
G |
Sele |
selectin E |
multiple interactions |
ISO |
[Vitamin E co-treated with Bezafibrate] results in decreased expression of SELE protein modified form |
CTD |
PMID:14602771 |
|
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Serpine1 |
serpin family E member 1 |
multiple interactions increases expression increases activity increases secretion |
ISO |
[CLOCK protein binds to BMAL1 protein] promotes the reaction [Bezafibrate results in increased expression of SERPINE1 mRNA]; Bezafibrate promotes the reaction [PPARA protein binds to SERPINE1 promoter]; CLOCK protein affects the reaction [Bezafibrate results in increased expression of SERPINE1 mRNA]; PPARA protein affects the reaction [Bezafibrate results in increased expression of SERPINE1 mRNA]; PPARA protein inhibits the reaction [Bezafibrate results in increased expression of SERPINE1 mRNA] Bezafibrate inhibits the reaction [[Oleic Acid co-treated with INS protein] results in increased expression of SERPINE1 mRNA]; Bezafibrate inhibits the reaction [[Oleic Acid co-treated with INS protein] results in increased expression of SERPINE1 protein] Bezafibrate results in increased activity of SERPINE1 protein Bezafibrate results in increased secretion of SERPINE1 protein |
CTD |
PMID:9678787 PMID:10364093 PMID:11292061 PMID:17118139 PMID:20400680 PMID:20854792 PMID:21757225 More...
|
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
EXP |
Bezafibrate inhibits the reaction [3-methylglutaric acid results in decreased expression of SIRT1 protein] |
CTD |
PMID:32169667 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slc27a1 |
solute carrier family 27 member 1 |
multiple interactions increases expression |
ISO |
PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of SLC27A1 mRNA] |
CTD |
PMID:19124612 |
|
NCBI chr16:18,278,984...18,300,173
Ensembl chr16:18,278,984...18,296,063
|
|
G |
Slc27a2 |
solute carrier family 27 member 2 |
multiple interactions increases expression |
ISO |
Bezafibrate inhibits the reaction [SLC27A2 gene mutant form results in decreased expression of ACADM mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of SLC27A2 mRNA] |
CTD |
PMID:11929713 PMID:17118139 PMID:19124612 |
|
NCBI chr 3:113,804,728...113,842,208
Ensembl chr 3:113,804,728...113,842,208
|
|
G |
Slc2a2 |
solute carrier family 2 member 2 |
multiple interactions decreases expression |
ISO EXP |
Bezafibrate inhibits the reaction [Oleic Acid results in increased expression of SLC2A2 mRNA] Bezafibrate results in decreased expression of SLC2A2 mRNA Diazoxide inhibits the reaction [Bezafibrate results in decreased expression of SLC2A2 mRNA] |
CTD |
PMID:11527545 PMID:12048068 |
|
NCBI chr 2:111,609,798...111,639,930
Ensembl chr 2:111,611,774...111,639,933
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
multiple interactions |
ISO |
Bezafibrate inhibits the reaction [Palmitates results in decreased expression of SLC2A4 mRNA] |
CTD |
PMID:21802492 |
|
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Smpd1 |
sphingomyelin phosphodiesterase 1 |
increases activity |
EXP |
[Bezafibrate results in increased activity of PPARA protein] which results in increased activity of SMPD1 protein |
CTD |
PMID:18024222 |
|
NCBI chr 1:159,892,946...159,896,789
Ensembl chr 1:159,892,859...159,896,794
|
|
G |
Smpd2 |
sphingomyelin phosphodiesterase 2 |
multiple interactions |
EXP |
[Bezafibrate results in increased activity of PPARA protein] which results in decreased activity of SMPD2 protein |
CTD |
PMID:18024222 |
|
NCBI chr20:44,986,229...44,989,343
Ensembl chr20:44,986,231...44,989,441
|
|
G |
Soat1 |
sterol O-acyltransferase 1 |
decreases activity |
EXP |
Bezafibrate results in decreased activity of SOAT1 protein |
CTD |
PMID:2044640 |
|
NCBI chr13:68,552,274...68,597,529
Ensembl chr13:68,552,317...68,597,494
|
|
G |
Sod1 |
superoxide dismutase 1 |
increases expression multiple interactions |
ISO |
Bezafibrate results in increased expression of SOD1 mRNA; Bezafibrate results in increased expression of SOD1 protein Bezafibrate inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in decreased expression of SOD1 mRNA] |
CTD |
PMID:11172467 PMID:18513333 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
multiple interactions decreases expression |
ISO |
Bezafibrate inhibits the reaction [IL6 protein results in increased expression of SPP1 mRNA]; Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [[FOS protein binds to JUN protein modified form] which binds to SPP1 promoter]]; Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SPP1 mRNA]; Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SPP1 protein]; Bezafibrate inhibits the reaction [TNF protein results in increased expression of SPP1 mRNA]; PPARA protein affects the reaction [Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SPP1 mRNA]] Bezafibrate results in decreased expression of SPP1 protein |
CTD |
PMID:17360982 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions decreases expression increases expression |
ISO EXP |
SREBF1 protein inhibits the reaction [cerivastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]] Bezafibrate results in decreased expression of SREBF1 mRNA; Bezafibrate results in decreased expression of SREBF1 protein [Bezafibrate results in decreased expression of SREBF1] which results in decreased abundance of Triglycerides; PPARA protein affects the susceptibility to [Bezafibrate results in decreased expression of SREBF1 mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of SREBF1 protein] Bezafibrate results in increased expression of SREBF1 mRNA; Bezafibrate results in increased expression of SREBF1 protein Bezafibrate inhibits the reaction [Dietary Fats results in increased expression of SREBF1 mRNA] |
CTD |
PMID:11779144 PMID:19124612 PMID:26190035 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
increases expression |
ISO |
Bezafibrate results in increased expression of SREBF2 mRNA |
CTD |
PMID:14685799 |
|
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
|
|
G |
Stat5b |
signal transducer and activator of transcription 5B |
decreases activity |
ISO |
Bezafibrate results in decreased activity of STAT5B protein |
CTD |
PMID:30114225 |
|
NCBI chr10:85,704,841...85,775,856
Ensembl chr10:85,705,670...85,775,668
|
|
G |
Suclg1 |
succinate-CoA ligase GDP/ADP-forming subunit alpha |
increases expression |
EXP |
Bezafibrate results in increased expression of SUCLG1 mRNA |
CTD |
PMID:16707586 |
|
NCBI chr 4:105,308,236...105,337,595
Ensembl chr 4:105,308,039...105,337,600
|
|
G |
Syp |
synaptophysin |
multiple interactions |
EXP |
Bezafibrate affects the reaction [3-nitropropionic acid affects the expression of SYP protein] |
CTD |
PMID:37116597 |
|
NCBI chr X:14,849,444...14,864,553
Ensembl chr X:14,849,444...14,864,745
|
|
G |
Tdg |
thymine-DNA glycosylase |
increases expression |
ISO |
Bezafibrate results in increased expression of TDG mRNA |
CTD |
PMID:15447978 |
|
NCBI chr 7:21,077,853...21,097,617
Ensembl chr 7:21,077,853...21,097,567
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions decreases expression |
ISO EXP |
Bezafibrate inhibits the reaction [TGFB1 protein results in increased expression of CCN2 protein] Bezafibrate inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of TGFB1 mRNA] Bezafibrate inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]; Bezafibrate inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]; Bezafibrate inhibits the reaction [TGFB1 protein results in increased expression of FN1 mRNA]; Bezafibrate inhibits the reaction [TGFB1 protein results in increased expression of TGFB1 mRNA] Bezafibrate results in decreased expression of TGFB1 mRNA |
CTD |
PMID:16574099 PMID:18513333 PMID:19429239 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Thra |
thyroid hormone receptor alpha |
decreases expression |
EXP |
Bezafibrate results in decreased expression of THRA mRNA |
CTD |
PMID:11519881 PMID:11579993 |
|
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
|
|
G |
Thrb |
thyroid hormone receptor beta |
decreases expression |
EXP |
Bezafibrate results in decreased expression of THRB mRNA |
CTD |
PMID:11519881 PMID:11579993 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Thrsp |
thyroid hormone responsive |
multiple interactions |
ISO |
Bezafibrate promotes the reaction [Oleic Acid results in decreased expression of THRSP mRNA] |
CTD |
PMID:24534255 |
|
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
multiple interactions |
ISO |
Bezafibrate inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of TIMP1 mRNA] |
CTD |
PMID:18513333 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
multiple interactions |
ISO |
Bezafibrate inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of TIMP2 mRNA] |
CTD |
PMID:18513333 |
|
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|
G |
Tnf |
tumor necrosis factor |
decreases response to substance increases response to substance decreases expression multiple interactions |
ISO EXP |
Bezafibrate results in decreased susceptibility to TNF protein Bezafibrate results in increased susceptibility to TNF protein Bezafibrate results in decreased expression of TNF mRNA; Bezafibrate results in decreased expression of TNF protein [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Bezafibrate promotes the reaction [TNF protein inhibits the reaction [FSHB protein results in increased secretion of Estradiol]]]; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Bezafibrate affects the susceptibility to [Lipopolysaccharides results in increased secretion of TNF protein]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Bezafibrate inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]; Bezafibrate inhibits the reaction [TNF protein results in increased expression of CCL5 protein]; Bezafibrate inhibits the reaction [TNF protein results in increased expression of SPP1 mRNA]; Bezafibrate promotes the reaction [TNF protein inhibits the reaction [FSHB protein results in increased secretion of Estradiol]]; Bezafibrate promotes the reaction [TNF protein results in decreased susceptibility to FSHB protein]; PPARG protein affects the reaction [Bezafibrate results in increased susceptibility to TNF protein] Bezafibrate inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of TNF mRNA] |
CTD |
PMID:11473052 PMID:11893366 PMID:12586603 PMID:12657956 PMID:16574099 PMID:17360982 PMID:18513333 PMID:21734263 PMID:32613381 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
multiple interactions |
ISO |
[Bezafibrate results in increased activity of PPARA protein] which results in increased expression of TRIB3 mRNA |
CTD |
PMID:19593819 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Ucp2 |
uncoupling protein 2 |
increases expression affects expression multiple interactions |
ISO EXP |
Bezafibrate results in increased expression of UCP2 mRNA Bezafibrate affects the expression of UCP2 mRNA [Bezafibrate binds to and results in increased activity of PPARA protein] which results in increased expression of UCP2 mRNA; Triiodothyronine promotes the reaction [Bezafibrate results in increased expression of UCP2 mRNA] |
CTD |
PMID:10933891 PMID:11056218 PMID:11341955 PMID:11473052 PMID:12588052 |
|
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
|
|
G |
Ucp3 |
uncoupling protein 3 |
increases expression decreases expression |
EXP ISO |
Bezafibrate results in increased expression of UCP3 mRNA Bezafibrate results in decreased expression of UCP3 mRNA |
CTD |
PMID:10342807 PMID:10403804 PMID:10909982 PMID:10933891 PMID:11473052 PMID:21324916 More...
|
|
NCBI chr 1:154,815,777...154,828,764
Ensembl chr 1:154,815,777...154,828,762
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases response to substance |
ISO |
UGT1A9 results in increased susceptibility to Bezafibrate |
CTD |
PMID:17880178 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2b1 |
UDP glucuronosyltransferase 2 family, polypeptide B1 |
increases glucuronidation |
EXP |
UGT2B1 protein results in increased glucuronidation of Bezafibrate |
CTD |
PMID:8302279 |
|
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
|
|
G |
Ugt2b7 |
UDP glucuronosyltransferase family 2 member B7 |
increases response to substance |
ISO |
UGT2B7 results in increased susceptibility to Bezafibrate |
CTD |
PMID:17880178 |
|
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
|
|
G |
Vbp1 |
VHL binding protein 1 |
increases expression |
ISO |
Bezafibrate results in increased expression of VBP1 mRNA |
CTD |
PMID:18787029 |
|
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions |
EXP ISO |
Bezafibrate inhibits the reaction [Streptozocin results in increased expression of VCAM1 mRNA] [Vitamin E co-treated with Bezafibrate] results in decreased expression of VCAM1 protein modified form |
CTD |
PMID:14602771 PMID:16979161 |
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vcan |
versican |
decreases expression |
ISO |
Bezafibrate results in decreased expression of VCAN mRNA |
CTD |
PMID:11522680 |
|
NCBI chr 2:20,761,718...20,860,637
Ensembl chr 2:20,761,718...20,860,637
|
|
G |
Vdr |
vitamin D receptor |
multiple interactions |
ISO |
[Calcitriol co-treated with Bezafibrate] results in increased expression of VDR mRNA |
CTD |
PMID:19667161 |
|
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
|
|
G |
Xdh |
xanthine dehydrogenase |
decreases activity decreases expression multiple interactions |
EXP |
Bezafibrate results in decreased activity of XDH protein Bezafibrate results in decreased expression of XDH protein Bezafibrate results in increased degradation of and results in decreased expression of XDH mRNA |
CTD |
PMID:8373410 |
|
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
G |
Zfp704 |
zinc finger protein 704 |
increases expression |
ISO |
Bezafibrate results in increased expression of ZFP704 mRNA |
CTD |
PMID:18787029 |
|
NCBI chr 2:92,171,804...92,356,059
Ensembl chr 2:92,171,496...92,351,282
|
|